137 related articles for article (PubMed ID: 11039096)
1. [Corticosteroid therapy of non-asthmatic chronic obstructive bronchopneumopathies].
Jébrak G; Pichot-Vérité MH; Marceau A; Rullon I
Presse Med; 2000 Sep; 29(16):1479-87. PubMed ID: 11039096
[TBL] [Abstract][Full Text] [Related]
2. [Official therapy guidelines for the family physician. Your time table in asthma].
Koczorek M
MMW Fortschr Med; 2002 Feb; 144(8):6-10. PubMed ID: 11910831
[No Abstract] [Full Text] [Related]
3. [Corticosteroid therapy and chronic obstructive bronchopneumopathies: the ISOLDE study].
Jébrak G
Presse Med; 2000 Sep; 29(16):1461-2. PubMed ID: 11039090
[No Abstract] [Full Text] [Related]
4. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
Paggiaro PL; Dahle R; Bakran I; Frith L; Hollingworth K; Efthimiou J
Lancet; 1998 Mar; 351(9105):773-80. PubMed ID: 9519948
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroid therapy in asthma: a balancing act.
Li JT
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
[No Abstract] [Full Text] [Related]
6. Do patients with COPD benefit from treatment with inhaled corticosteroids?
van Schayck CP; van Grunsven PM; Dekhuijzen PN
Eur Respir J; 1996 Oct; 9(10):1969-72. PubMed ID: 8902451
[No Abstract] [Full Text] [Related]
7. [Corticosteroid therapy of asthma].
Chanez P; Vachier I; Michel FB; Bousquet J; Godard P
Presse Med; 2000 Sep; 29(16):1469-78. PubMed ID: 11039095
[TBL] [Abstract][Full Text] [Related]
8. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
Lipworth BJ
Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
[TBL] [Abstract][Full Text] [Related]
9. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate.
Wolthers OD
Recent Pat Inflamm Allergy Drug Discov; 2015; 9(2):144-50. PubMed ID: 26581314
[TBL] [Abstract][Full Text] [Related]
11. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
[TBL] [Abstract][Full Text] [Related]
12. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ; Currie GP; Lipworth BJ
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[TBL] [Abstract][Full Text] [Related]
13. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma.
Chalmers GW; Macleod KJ; Little SA; Thomson LJ; McSharry CP; Thomson NC
Thorax; 2002 Mar; 57(3):226-30. PubMed ID: 11867826
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
15. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
Jarvis B; Faulds D
Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
[TBL] [Abstract][Full Text] [Related]
16. [Asthma and obstructive bronchopneumopathies: the consensus].
Yernault JC
Rev Med Brux; 1996 Sep; 17(4):263-5. PubMed ID: 8927858
[TBL] [Abstract][Full Text] [Related]
17. Controlled short-term trial of fluticasone propionate in ventilator-dependent patients with COPD.
Nava S; Compagnoni ML
Chest; 2000 Oct; 118(4):990-9. PubMed ID: 11035668
[TBL] [Abstract][Full Text] [Related]
18. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
[TBL] [Abstract][Full Text] [Related]
19. Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible?
van Schayck CP; van den Broek PJ; den Otter JJ; van Herwaarden CL; Molema J; van Weel C
JAMA; 1995 Jul; 274(2):161-4. PubMed ID: 7596005
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid-sparing effect of azelastine in the management of bronchial asthma.
Busse WW; Middleton E; Storms W; Dockhorn RJ; Chu TJ; Grossman J; Weiler JM; Bronsky EA; Mansfield LE; Bell TD; Hemsworth GR; Perhach JL; D'Eletto TA; Dam A
Am J Respir Crit Care Med; 1996 Jan; 153(1):122-7. PubMed ID: 8542104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
